Skip to content
ppharmaranks
Menu
Class IIOngoing

Kapsin Ointment recall

FDA recall D-0376-2025 · initiated Apr 9, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 30, 2025How we research

Apipharma recalled Kapsin Ointment in Apr 2025 — an FDA Class II recall (D-0376-2025) because CGMP Deviations.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 153211, Exp.: 2025-04; 210221, Exp.: 2026-05.

Quantity recalled: 5,095 cartons

Details

Product
Kapsin Ointment, Camphor 3.16% and Capsaicin 0.03%. Net Wt. 2 oz (60g) tubes, Manufactured by: Apipharma d.o.o, Jeronima Kavanjina 26, 10090 Zagreb, Croatia, Distributed by: Apipharma, LLC, 2331 West Alameda Drive, Tempe, AZ 85282 UPC 3 858882 101363
Recalling company
Apipharma
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
AZ
Initiated
Apr 9, 2025
FDA report date
Apr 30, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Kapsin Ointment recalled?
Apipharma recalled Kapsin Ointment in Apr 2025 — an FDA Class II recall (D-0376-2025) because CGMP Deviations. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Kapsin Ointment recalled?
Per the FDA enforcement record, the reason for recall D-0376-2025 was: CGMP Deviations
Is a recalled Kapsin Ointment dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Kapsin Ointment are affected?
Distributed: AZ. The recall covers these lots — Lot #: 153211, Exp.: 2025-04; 210221, Exp.: 2026-05.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0376-2025.

Source: openFDA Drug Enforcement record D-0376-2025

← All drug recalls